Brief: Champions Biotechnology Reports Qtrly Loss Per Share $0.17

Champions Oncology

27/07/2020 23:28

July 27 (Reuters) - Champions Biotechnology  Inc  CSBR.O :
    * CHAMPIONS BIOTECHNOLOGY  INC - FORECAST REVENUE GROWTH OF
15% -
20% IN FY 2021
    * CHAMPIONS BIOTECHNOLOGY  INC - QTRLY REVENUE INCREASED
13.4% TO
$8.8 MILLION
    * CHAMPIONS BIOTECHNOLOGY  INC - QTRLY LOSS PER SHARE $0.17

Source: (https://bit.ly/2CJrtnb)
Further company coverage:  CSBR.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))